X-Linked Retinitis Pigmentosa Clinical Trial
Official title:
Natural History of the Progression of X-Linked Retinitis Pigmentosa
The objective of the study is to gain a better understanding of disease progression over time in participants with X-linked retinitis pigmentosa (XLRP).
This study was previously posted by NightstaRx Ltd. In October, 2020, sponsorship of the trial was transferred to Biogen. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05926583 -
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
|
Phase 3 | |
| Enrolling by invitation |
NCT06275620 -
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
|
Phase 2 | |
| Completed |
NCT03116113 -
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04850118 -
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04517149 -
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT03584165 -
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
|
Phase 3 | |
| Active, not recruiting |
NCT04312672 -
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
|
||
| Completed |
NCT04868916 -
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
|
||
| Completed |
NCT03252847 -
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05874310 -
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
|
Early Phase 1 | |
| Active, not recruiting |
NCT04794101 -
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
|
Phase 3 | |
| Active, not recruiting |
NCT04671433 -
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
|
Phase 3 | |
| Completed |
NCT03314207 -
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)
|
||
| Active, not recruiting |
NCT03316560 -
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT06333249 -
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
|
Phase 2 |